0001209191-20-013034.txt : 20200226 0001209191-20-013034.hdr.sgml : 20200226 20200226163628 ACCESSION NUMBER: 0001209191-20-013034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20656317 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2020-02-24 4 F 0 3156 239.23 D 36291 D Common Stock 2020-02-25 4 S 0 953 230.00 D 35338 D Common Stock 2020-02-25 4 S 0 270 230.98 D 35068 D Common Stock 2020-02-25 4 S 0 450 232.62 D 34618 D Common Stock 2020-02-25 4 S 0 90 233.18 D 34528 D Common Stock 2020-02-25 4 S 0 533 234.56 D 33995 D Common Stock 2020-02-25 4 S 0 360 235.75 D 33635 D Common Stock 2020-02-25 4 S 0 180 236.63 D 33455 D Common Stock 2020-02-25 4 S 0 540 238.33 D 32915 D Common Stock 16190 I Held in Trust Common Stock 882 I 401(k) Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $230.00 (range $229.52 to $230.31). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $230.98 (range $230.57 to $231.26). Open market sales reported on this line occurred at a weighted average price of $232.62 (range $232.06 to $233.05). Open market sales reported on this line occurred at a weighted average price of $234.56 (range $234.27 to $234.66). Open market sales reported on this line occurred at a weighted average price of $235.75 (range $235.63 to $235.82). Open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.54). /s/ Omar White, Attorney-in-Fact 2020-02-26